
SeaX Leads $1.6M Funding Round for US Cardiac Wearable Startup Skribe
US cardiac wearable startup Skribe has secured $1.6 million in a funding round led by SeaX. The company develops the Aurora system, an innovative medical technology that combines a multi-sensor adhesive patch with artificial intelligence analysis to estimate left ventricular ejection fraction. This early-stage investment highlights growing interest in AI-driven healthcare solutions and wearable cardiac monitoring technologies.
Key Takeaways
- SeaX led a $1.6 million funding round for US cardiac wearable startup Skribe.
- Skribe's core innovation is the Aurora system.
- The Aurora system integrates a multi-sensor adhesive patch with AI analysis.
- The technology is designed to estimate left ventricular ejection fraction.
In-Depth Analysis
Skribe Secures $1.6M Led by SeaX
US-based cardiac wearable startup Skribe has successfully raised $1.6 million in a funding round. The investment was led by SeaX, marking a notable milestone for the early-stage medical technology company as it looks to advance its product development and market presence.
The Aurora System: Combining Sensors and AI
The central focus of Skribe's technology is the Aurora system. This medical solution uniquely combines a multi-sensor adhesive patch with advanced artificial intelligence analysis. By merging continuous patch-based data collection with AI processing, the system is engineered to estimate left ventricular ejection fraction, providing a specialized approach to cardiac monitoring.
Industry Impact
The investment by SeaX into Skribe underscores the ongoing convergence of artificial intelligence and wearable medical devices within the healthcare sector. Solutions that streamline cardiac assessment, such as estimating left ventricular ejection fraction via non-invasive patches and AI, represent an evolving area of interest for investors and healthcare providers seeking more efficient diagnostic tools.
Frequently Asked Questions
Question: Who led the $1.6 million funding round for Skribe?
Answer: The funding round for Skribe was led by SeaX.
Question: What is the primary product developed by Skribe?
Answer: Skribe developed the Aurora system, which combines a multi-sensor adhesive patch with AI analysis to estimate left ventricular ejection fraction.


